Thinking About Ob/Gyn

Menopause hormone therapy is everywhere right now, and we sort science from hype using the newest ACP and ACOG guidance. We explain why the treatment is often simpler than social media claims, and how to spot hormone grift without dismissing real symptoms. • menopause hype and the rise of cash-pay menopause clinics • the medical hype cycle and how WHI shaped fear and overcorrection • ACP guideline: estrogen with progestogen first line for vasomotor symptoms when a uterus is present • nonhormonal options and where SSRIs, SNRIs, gabapentin, and neurokinin receptor antagonists fit • route myths: why transdermal is not proven “safer” than oral for rare harms • ACOG guidance on vasomotor symptoms, sleep disturbance, mood symptoms, timing of initiation, and contraindications • perimenopause management: contraception-based ovarian suppression versus MHT supplementation • why routine hormone testing, AMH, saliva, urine, and dried urine panels do not guide care • testosterone reality check: limited indications, superphysiologic dosing, and potential cardiovascular risk • four red flags for social media hormone grifters: broad cure-all claims, hormone testing products, compounded hormones and pellets, excessive testosterone Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram. 0:01 Why Menopause Is Everywhere5:54 The Hype Cycle Behind Hormones11:12 ACP Guideline First Line Treatment14:41 Transdermal Versus Oral Risk Claims17:54 ACOG Vasomotor Sleep Mood Guidance26:46 Perimenopause Toolkit And Lab Testing32:05 Testosterone Risks And Overuse34:19 Four Red Flags For Hormone GriftersFollow us on Instagram @thinkingaboutobgyn.

We talk with Dr. Jason Knight about what burnout really looks like in medicine and why a hard day is not the same thing as a broken relationship with the work. We push past buzzwords to name root causes, moral injury, and the practical steps clinicians and leaders can take to rebuild a sustainable healthcare workforce. • distinguishing clinical exhaustion from burnout using emotional exhaustion, efficacy, and depersonalization • why generic wellness programs fail when they are not matched to the real driver • the limits of resilience and why burnout is a shared workplace problem • the six-domain mismatch model: workload, control, reward, community, fairness, values • how rural care, maternity deserts, and legal constraints amplify workload and control gaps • moral injury in healthcare and how it differs from second victim syndrome • building better measurement than once-a-year engagement surveys • having productive leadership conversations by pairing data with real stories • creating psychological safety for learners and addressing power dynamics • returning to center through presence, journaling, and community • using the Maslach Burnout Inventory to name what is mismatched • normalizing “I need help” and reducing isolation as a risk factor • Dr. Knight’s 78-Day Spiritual Reset and why reflection can support recovery Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram 0:00 Welcome And Guest Setup1:28 Wellness Without Root Cause 3:10 Burnout Versus Exhaustion Defined6:56 Resilience And System Failures12:34 Six Burnout Mismatch Domains19:37 Moral Injury And Second Victim27:13 Track Wellness Beyond Annual Surveys29:21 How To Talk With Leadership38:17 Returning To Center Through Presence44:34 Practical Tools To Get Help53:20 Reasons For Hope And FarewellFollow us on Instagram @thinkingaboutobgyn.

We dig into how good stories and elegant mechanisms can seduce clinicians into using fertility and surgical “add-ons” long before the evidence is ready. We also connect policy, access, and misinformation to a disturbing rise in ectopic pregnancy deaths, then end with what better studies should look like when patient safety is on the line. • why low-dose naltrexone becomes a fertility add-on despite unclear mechanisms • biologic plausibility versus proof, and why theory cannot replace trials • what the available LDN data looks like, including weak endpoints and missing live birth outcomes • practice inertia, file drawer bias, and when a therapy belongs in routine care • ProPublica’s ectopic pregnancy mortality signal and how to interpret CDC WONDER data • COVID-era care disruptions, hospital closures, and delayed early pregnancy evaluation • Dobbs-era legal ambiguity, chilling effects, and implications for methotrexate timing • a new Nature Medicine finding on ISM2 as an early biomarker for preeclampsia and fetal growth restriction • V-NOTES versus vaginal hysterectomy trial design problems, including power, exclusions, and comparators • conflicts of interest, blinding failures, and how low-quality studies pollute meta-analyses Everybody remember to get your ABOG stuff done in the next month or so. Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram. 0:34 Low-Dose Naltrexone For Fertility8:38 Evidence Gaps And Practice Inertia17:14 Ectopic Pregnancy Deaths Are Rising22:00 Access Problems And Social Media Misinformation24:15 Abortion Bans And Delayed Ectopic Care29:32 ISM2 Biomarker For Preeclampsia Risk32:31 V-Notes Versus Vaginal Hysterectomy Study41:40 Power, Outcomes, And Unfair Comparisons47:50 Conflict Of Interest And Broken Blinding55:09 Where V-Notes Came From1:01:31 Skills, Tradeoffs, And Final RemindersFollow us on Instagram @thinkingaboutobgyn.

Tara Chettiar joins as we talk through what the Lindsay Clancy case surfaces about postpartum mood disorders and why the public often misunderstands psychiatric illness when it gets filtered through legal arguments and internet certainty. We focus on practical clinical signals, especially sleep disruption, and what real safety planning and system reform should look like for postpartum families. • why we avoid diagnosing a public case and instead look for system lessons • how legal “insanity” clashes with the clinical spectrum of impairment • why med lists get misread and what SSRI activation can signal • baby blues versus postpartum depression and postpartum anxiety over time • postpartum OCD intrusive thoughts versus psychosis and delusions • sleep deprivation as the clearest danger sign and how it presents • what families can do in an acute postpartum mental health crisis • first line outpatient medication basics for OB GYN care • why postpartum psychosis needs emergency level triage • mother baby units and why the US has so few • what a postpartum mental health safety plan includes, including guns and pills • better screening in pregnancy, EPDS versus PHQ-9, and why anxiety matters • workforce gaps and why OBs, family medicine, pediatrics, and ER teams need training • Resources: Postpartum Support International at 1-800-944-4773 and text help, the National Maternal Mental Health Hotline at 833-TLC-Mama (852-6262), and 988 Be sure to check out thinking about obgyn.com for more information. And be sure to follow us on Instagram. 0:00 Welcome And Trigger Warning1:30 Meet Tara And Her Work7:10 Why The Clancy Case Matters11:55 Legal Binary Versus Clinical Reality12:50 Med Lists And Public Misreads14:50 SSRI Insomnia And Bipolar Red Flags18:15 Baby Blues Through Psychosis Spectrum24:00 Intrusive Thoughts Versus Psychosis28:13 Sleep Loss And Family Warning Signs30:45 First Line Meds And Titration34:55 ER Triage And Postpartum Advocacy39:05 Mother Baby Units And Step Down Care42:30 Safety Plans Means And Support45:35 Screening Tools EPDS Over PHQ948:05 Workforce Gaps And Training Fixes49:55 Policy Social Support And Paid Leave52:40 Hotlines Resources And Closing ThoughtsFollow us on Instagram @thinkingaboutobgyn.

We move from a Dolly Parton story to the very real ways policy, training, and clinical guidance shape what patients can access and what clinicians can safely provide. We break down the end of global OB billing, the risks of vaccine schedule “tweaks,” and why surgical convenience can quietly drive worse care. • rural maternity deserts and why reimbursement must cover facility costs • content warnings and protecting our own mental health while learning from high-profile perinatal cases • the shift from global maternity fees to E/M problem-based prenatal visits • work RVUs, delivery billing and why correct coding matters • measles deaths, herd immunity and why splitting MMR increases missed protection • robotic surgery dominance, laparoscopic deskilling and training priorities • ACOG opportunistic salpingectomy guidance for ovarian cancer prevention • practical techniques to complete salpingectomy during vaginal hysterectomy • listener question on urinary retention and pudendal nerve injury myths 0:00 Welcome And A Dolly Parton Story6:07 Perinatal Mental Health And Content Warnings8:20 OB Billing Shifts From Global To E/M15:17 Measles Deaths And The MMR Split20:05 Robotic Dominance And Laparoscopy Deskilling31:41 ACOG Salpingectomy Guidance And Ovarian Cancer40:53 Vaginal Hysterectomy Tube Removal Techniques53:10 Urinary Retention And Pudendal Nerve Myths1:06:22 Final Takeaways And Where To FollowThanks for listening be sure to check out thinkingaboutobyn.com for more information and be sure to follow us on Instagram Follow us on Instagram @thinkingaboutobgyn.

JJ Cox joins us as we talk through what actually changes when we perform cesarean delivery in patients with morbid obesity, from incision planning to anesthesia risk to the wound that has to heal at home. We share practical tips, review key trials on negative pressure dressings and antibiotics, and focus on decisions that protect both safe delivery and lower wound complications. • panniculus anatomy driving incision choice more than BMI • using ultrasound to find the uterus when landmarks mislead • paniculus retraction treated as an anesthesia maneuver • distance and geometry limiting exposure and delivery technique • planning the wound’s postoperative “home” before making the cut • negative pressure wound therapy evidence including the 2020 JAMA trial and skin blistering risk • skin glue vs standard dressings as competing narratives with limited data • closing deep subcutaneous space in layers to reduce dead space • avoiding staples and favoring subcuticular suture based on available evidence • antibiotic prophylaxis realities including azithromycin dose questions and shortage workarounds • extended postoperative antibiotics data shift when azithromycin is already used • OR contamination habits including Yankauer discipline and glove-changing debate • calling for help early and building a short pre-op plan to prevent downstream problems Be sure to check out thinking about obgyn.com for more information. And be sure to follow us on Instagram. 0:00 Welcome And Guest Introduction2:55 Why These C-Sections Are Higher Risk7:00 Picking The Incision With Ultrasound14:25 Panniculus Retraction Is Anesthesia Critical17:35 Delivery Tips When Distance Is The Enemy19:55 Think About The Wound Before Cutting24:20 Negative Pressure Dressings What Trials Show34:45 Subcutaneous Closure Sutures Beat Shortcuts38:55 Antibiotics Dosing Azithromycin Reality Check45:55 Contamination Control Yankauer And Gloves52:10 Assistance Planning And Hemorrhage Limits55:30 Meta-Analysis Takeaways And ClosingFollow us on Instagram @thinkingaboutobgyn.

We challenge a few stubborn pieces of OB-GYN “common sense” and ask what the data actually supports, from trying to conceive after miscarriage to how we start and adjust ovulation induction. Then we shift into practical laparoscopy tips for obese patients and end with a sober look at how evidence quality shapes care, from magnesium sulfate debates to the rise in pregnancy-associated overdose deaths. • why waiting a full cycle after first-trimester miscarriage lacks evidence for better outcomes • why routine progestin withdrawal bleeds before letrozole or clomiphene can be unnecessary and even harmful • how stair-stepping ovulation induction dosing can shorten time to ovulation • four operating room tips for minimally invasive surgery in morbid obesity, including port geometry and Trendelenburg dry runs • what a recent D&E fetal demise paper suggests about DIC and hemorrhage risk beyond 28 days • why retrospective birth registry studies can mislead when randomized trial data exist • how Medicaid timing findings highlight confounding rather than causation • a clever low-port approach to perforated IUD removal using a transabdominal hysteroscope • why overdose deaths are rising faster in pregnant and postpartum people and what fentanyl changes Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram.0:00 Welcome And What We’re Reading0:29 The Myth Of Waiting After Miscarriage1:08 Skip The Provera Withdrawal Bleed7:49 Data On Conceiving Sooner13:52 Laparoscopy Setup For Obese Patients25:07 D&E After Second Trimester Demise28:39 Magnesium Sulfate And Study Quality39:06 Medicaid Timing And Confounding44:57 Single Port Perforated IUD Removal49:33 Overdose As Leading Pregnancy Associated Death57:57 Book Shout Out And ClosingFollow us on Instagram @thinkingaboutobgyn.

Howard Herrell and Stuart Winkler question long-standing OB-GYN habits that feel “routine” but do not add value, then replace them with evidence and practical decision-making. We move from hysterectomy follow-up and cuff dehiscence management to the data behind cesarean sutures, endometrial cancer evaluation in postmenopausal bleeding, and the ongoing shift to HPV-based cervical cancer screening. • why routine 6 to 8 week vaginal cuff exams after hysterectomy may not prevent or predict dehiscence • how telehealth post-op care can improve access while keeping symptom-driven safety nets • four tips for evaluating and managing vaginal cuff dehiscence, including when laparoscopy matters • what Ethicon discontinuing chromic and plain gut could mean for cesarean technique choices • how the CORONIS trial informs chromic vs Vicryl decisions and why transfusion risk is part of the conversation • where the 4 mm endometrial stripe rule came from and why it can fail in real-world care • why persistent postmenopausal bleeding still warrants endometrial biopsy despite reassuring ultrasound • how race, tumor subtype, and fibroids affect endometrial cancer detection and counseling • the arc from Pap smear cytology to HPV DNA testing, vaccines, and primary HPV screening • why self-collected HPV testing may raise screening uptake for patients avoiding speculum exams Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram.0:00 Welcome And Today’s Game Plan0:35 Rethinking The Six-Week Pelvic Exam13:25 Four Practical Tips For Cuff Dehiscence24:42 Chromic Gut Is Disappearing35:40 CORONIS Trial And Cesarean Sutures42:22 Postmenopausal Bleeding And The 4 mm Rule53:12 HPV Testing Takes Over ScreeningFollow us on Instagram @thinkingaboutobgyn.

We follow the footnotes on a common gyn rule, then use that same evidence-first lens to question popular fertility add-ons and persistent pregnancy myths. Along the way, we talk pretest probability, counseling tradeoffs, and why simple cutoffs often replace better clinical reasoning. • tracing the “biopsy Bartholin cysts after 40” claim back to weak citations • using pretest probability and exam features to decide on selective biopsy • weighing hysteropexy versus hysterectomy for prolapse with long-term cancer risk in mind • breaking down a Lancet review of IVF add-ons and what actually shows benefit • spotting how marketing and online forums amplify unproven fertility interventions • reviewing data on sedentary time in pregnancy and why activity restriction persists • debunking “walking progresses labor” with randomized trial evidence • clarifying early diabetes testing as screening for preexisting diabetes and when A1C makes more sense than early glucose tolerance tests Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram.0:00 Welcome And What’s Ahead0:23 Bartholin Cyst Biopsy Age Rule14:17 Prolapse Repair With Uterus Preservation21:45 IVF Add-Ons And The Lancet Review37:35 Pregnancy Activity Myths And New Data50:53 Early Diabetes Testing And A1CFollow us on Instagram @thinkingaboutobgyn.

Howard and guest hose Sivani Aluru unpack why the new PMOS name matters, how PCOS got tied to “cysts,” and what the evidence actually says about diagnosis, metabolic risk, and treatment. We also challenge a few habits we have all inherited, from pre-op antibiotic dosing to the way we talk about hormones, weight, and fertility with patients. • the evidence gap behind 2 g vs 3 g cefazolin in obese cesarean patients and how practice inertia forms • why PMOS shifts attention toward insulin resistance, metabolic screening, and multidisciplinary care • how NIH, Rotterdam, and androgen excess criteria shape who gets diagnosed and who gets missed • SHBG and free testosterone as a practical way to explain symptoms when total testosterone looks normal • why ovarian follicles are not the same as painful ovarian cysts and why ultrasound can mislead • patient frustration with “just take birth control” and how we explain progesterone protection for the endometrium • lean PMOS, weight-focused bias, and realistic conversations about lifestyle change, GLP-1s, and bariatric surgery • fertility takeaways from PPCOS II, metformin limitations, and what lifestyle trials suggest preconception Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram.0:00 Welcome And Guest Introduction2:01 The 3-Gram Ancef Habit12:02 PCOS Becomes PMOS12:55 How The Criteria Got Complicated22:00 Insulin Resistance And Free Testosterone30:40 Hormone Panels And TikTok Myths32:30 Ovarian Follicles Are Not “Cysts”36:03 Treating Symptoms Without Dismissing People46:12 Fertility Trials And Lifestyle Results57:27 ACOG At 75 And Why JoinFollow us on Instagram @thinkingaboutobgyn.